Clinical Trial Update: Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase [Phase 4]

View source ↗

Summary

Phase 4 trial comparing bromfenac 0.09% to ketorolac 0.4% as part of cyclosporine induction for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• BROMFENAC (Bromfenac)
• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Florida Eye Microsurgical Institute | Conditions: Dry Eye Disease, Ocular Comfort | Phase 4 | Status: COMPLETED